Byrne Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2K | Hold |
27
| – | – | 0.01% | 369 |
|
|
2025
Q1 | $17.1K | Buy |
+27
| New | +$17.1K | 0.01% | 355 |
|
|
2024
Q4 | – | Sell |
-41
| Closed | -$43.1K | – | 262 |
|
|
2024
Q3 | $43.1K | Hold |
41
| – | – | 0.03% | 215 |
|
|
2024
Q2 | $43.1K | Hold |
41
| – | – | 0.03% | 217 |
|
|
2024
Q1 | $39.5K | Hold |
41
| – | – | 0.03% | 221 |
|
|
2023
Q4 | $35.8K | Hold |
41
| – | – | 0.03% | 221 |
|
|
2023
Q3 | $34K | Hold |
41
| – | – | 0.03% | 222 |
|
|
2023
Q2 | $29K | Hold |
41
| – | – | 0.02% | 287 |
|
|
2023
Q1 | $34K | Hold |
41
| – | – | 0.02% | 256 |
|
|
2022
Q4 | $29.6K | Sell |
41
-7
| -15% | -$5.05K | 0.02% | 280 |
|
|
2022
Q3 | $33K | Hold |
48
| – | – | 0.03% | 238 |
|
|
2022
Q2 | $28K | Hold |
48
| – | – | 0.02% | 238 |
|
|
2022
Q1 | $34K | Sell |
48
-6
| -11% | -$4.25K | 0.02% | 252 |
|
|
2021
Q4 | $34K | Buy |
+54
| New | +$34K | 0.02% | 244 |
|